Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 1
2008 1
2009 1
2013 1
2014 3
2015 1
2016 2
2017 4
2018 4
2019 1
2020 4
2021 5
2022 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Kerfuffle!
Grasela TH, Ludwig E, Fiedler-Kelly J. Grasela TH, et al. Among authors: fiedler kelly j. J Clin Pharmacol. 2009 Apr;49(4):386-8. doi: 10.1177/0091270008330159. J Clin Pharmacol. 2009. PMID: 19318691
Challenges in the transition to model-based development.
Grasela TH, Fiedler-Kelly J, Walawander CA, Owen JS, Cirincione BB, Reitz KE, Ludwig EA, Passarell JA, Dement CW. Grasela TH, et al. Among authors: fiedler kelly j. AAPS J. 2005 Oct 5;7(2):E488-95. doi: 10.1208/aapsj070249. AAPS J. 2005. PMID: 16353926 Free PMC article. Review.
Pharmacokinetics of Tedizolid in Obese and Nonobese Subjects.
Flanagan S, Minassian SL, Passarell JA, Fiedler-Kelly J, Prokocimer P. Flanagan S, et al. Among authors: fiedler kelly j. J Clin Pharmacol. 2017 Oct;57(10):1290-1294. doi: 10.1002/jcph.928. Epub 2017 May 16. J Clin Pharmacol. 2017. PMID: 28510339 Clinical Trial. No abstract available.
Exposure-Efficacy Analyses Support Optimal Dosing Regimens of Ceftolozane/Tazobactam in Participants with Hospital-Acquired/Ventilator-Associated Bacterial Pneumonia in ASPECT-NP.
Gao W, Passarell J, Patel YT, Zhang Z, Lin G, Fiedler-Kelly J, Bruno CJ, Rhee EG, De Anda CS, Feng HP. Gao W, et al. Among authors: fiedler kelly j. Antimicrob Agents Chemother. 2022 May 17;66(5):e0139921. doi: 10.1128/aac.01399-21. Epub 2022 Apr 26. Antimicrob Agents Chemother. 2022. PMID: 35471040 Free PMC article. Clinical Trial.
Concentration-QTc analysis of quizartinib in patients with relapsed/refractory acute myeloid leukemia.
Kang D, Ludwig E, Jaworowicz D, Huang H, Fiedler-Kelly J, Cortes J, Ganguly S, Khaled S, Krämer A, Levis M, Martinelli G, Perl A, Russell N, Abutarif M, Choi Y, Yin O. Kang D, et al. Among authors: fiedler kelly j. Cancer Chemother Pharmacol. 2021 Apr;87(4):513-523. doi: 10.1007/s00280-020-04204-y. Epub 2021 Jan 8. Cancer Chemother Pharmacol. 2021. PMID: 33415416 Free PMC article.
Data standards for model-informed drug development: an ISoP initiative.
Radivojevic A, Corrigan B, Downie N, Fox R, Fiedler-Kelly J, Liu H, Melhem M, Radke D, Schaefer P, Su J, Swat MJ, Teuscher NS, Thanneer N, Zong A, Wilkins JJ. Radivojevic A, et al. Among authors: fiedler kelly j. J Pharmacokinet Pharmacodyn. 2018 Oct;45(5):659-661. doi: 10.1007/s10928-018-9595-8. Epub 2018 Jul 25. J Pharmacokinet Pharmacodyn. 2018. PMID: 30046963 No abstract available.
30 results